ArticleJournal of the mechanical behavior of biomedical materials2026
Biodegradable and osteoconductive sodium alginate-gelatin/amorphous magnesium phosphate 3D-printed scaffolds for craniofacial bone regeneration.
Article in Journal of the mechanical behavior of biomedical materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hydrogel Implementing Drug Delivery in Cranial Bone Tissue Engineering.Journal of functional biomaterials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aimed (1) to develop and characterize 3D-printed hydrogel-based scaffolds composed of sodium alginate and gelatin containing amorphous magnesium phosphate (AMP), and (2) to evaluate the scaffolds' biological response with alveolar bone-derived mesenchymal stem cells (aBMSCs). Hydrogel inks were prepared with sodium alginate, gelatin, calcium chloride, and varying AMP contents (0 %, 5 %, and 10 %). The scaffolds were fabricated using an extrusion-based 3D bioprinter. First, the formulated hydrogel-based inks were characterized for rheological behavior and printability. After printing, the scaffolds were assessed for morphology, chemical composition, mechanical properties, and swelling/degradation profiles. For in vitro cell-scaffold interaction, scaffolds were seeded with aBMSCs and analyzed for cell viability, matrix mineralization, and osteogenic gene expression via RT-qPCR. Statistical analysis was performed with ANOVA/Sidak or Tukey tests, with confidence intervals (α = 5 %). Rheological analysis showed that all inks exhibited shear-thinning behavior, more pronounced in AMP-containing formulations. Filament drop tests and printability assessments demonstrated filament uniformity and structural fidelity in AMP-containing inks. Morphological analysis revealed well-defined scaffold architecture with regular edges, and SEM confirmed smooth surface morphology with uniform AMP distribution. FTIR spectra displayed characteristic phosphate and polymer bands, while EDS confirmed the presence of magnesium and phosphorus in AMP-containing scaffolds. The swelling behavior increased over 24 h, and all 3D-printed scaffolds fully degraded within 35 days. All formulations supported increased cell viability over time (p ≤ 0.0092). AMP-containing scaffolds enhanced mineralized matrix deposition under osteogenic stimulation (p < 0.0001), particularly in the 10 % AMP group, and promoted upregulation of osteogenic genes (COL1A1, ALPL, and RUNX2). Clinical significance: This study demonstrated that incorporating AMP into alginate-based hydrogels combines printability, biodegradability, and osteoconductive properties. Previous AMP-containing biomaterials lacked optimization for material extrusion-based 3D printing or the synergistic combination with a gelatin-alginate network. This strategy represents an advance in the field, offering a potential biomaterial ink for the fabrication of personalized scaffolds for craniofacial bone regeneration, enabling synergistic modulation of rheology and early osteogenic stimulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.